NCT00923065
Data Collection, Clinical Care and Interventions in CCR, NCI
Enrolling by Invitation
Not specifiedAges 4+ObservationalNational Cancer Institute (NCI)Government-funded
~10,000 participants
Updated 2026-07-28 on ClinicalTrials.gov
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
establishment of data repository for standard of care participants
Measured over ongoing
Conditions
Where it's being run
1 sites across 1 statesMaryland1
Study leadership
- Fatima H Karzai, M.D. · PRINCIPAL_INVESTIGATOR · National Cancer Institute (NCI)
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Individuals must be age 2 years or older if therapeutic interventions are required. Otherwise, there are no age restrictions beyond the neonatal period (4 weeks).
Individuals will be eligible if they meet one of the following criteria:
are seeking a consultation from NCI/CCR.
whose medical welfare will be seriously compromised by referral back to the community, such as rare/complex diseases in which community treatment is inadequate or adequate community resources are unavailable.
have cancer, HIV, or are at risk for cancer and/or HIV for whom cancer evaluation, treatment or management at the NCI is requested.
who will serve or have served as cellular therapy donors, for the treatment of a recipient of cellular therapy on an NCI trial.
are participants or biologic family members of deceased participants, where genetic testing is required or a clinically actionable germline pathogenic or likely pathogenic variant with medical implications was discovered by a research laboratory that requires CLIA confirmation. Note: In some cases, enrollment onto this study is also necessary when the prior study on which the involved participant was originally enrolled is closed and/or the participant is now off study.
The individual or their Legally Authorized Representative is able and willing to provide informed consent.
What this trial measures
- establishment of data repository for standard of care participantsongoing
Obtain and store information from participants seen for consult, treatment and medical follow-up for NCI patients, other Institute patients and individuals as specified.